These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 15533448)

  • 21. Semiautomated cell-free conversion of prion protein: applications for high-throughput screening of potential antiprion drugs.
    Breydo L; Bocharova OV; Baskakov IV
    Anal Biochem; 2005 Apr; 339(1):165-73. PubMed ID: 15766724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prions and their biology].
    Gasset M; Westaway D
    Rev Neurol; 2000 Jul 16-31; 31(2):129-32. PubMed ID: 10951668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The highways and byways of prion protein trafficking.
    Campana V; Sarnataro D; Zurzolo C
    Trends Cell Biol; 2005 Feb; 15(2):102-11. PubMed ID: 15695097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amyloids, prions and the inherent infectious nature of misfolded protein aggregates.
    Soto C; Estrada L; Castilla J
    Trends Biochem Sci; 2006 Mar; 31(3):150-5. PubMed ID: 16473510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Species-barrier phenomenon in prion transmissibility from a viewpoint of protein science.
    Hagiwara K; Hara H; Hanada K
    J Biochem; 2013 Feb; 153(2):139-45. PubMed ID: 23284000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro conversion of mammalian prion protein into amyloid fibrils displays unusual features.
    Baskakov IV; Bocharova OV
    Biochemistry; 2005 Feb; 44(7):2339-48. PubMed ID: 15709746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prion/lipid hypothesis--further evidence to support the molecular basis for transmissible spongiform encephalopathy risk assessment.
    Gale P
    J Appl Microbiol; 2007 Dec; 103(6):2033-45. PubMed ID: 18045387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prion protein interconversions.
    Caughey B
    Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):197-200; discussion 200-2. PubMed ID: 11260800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does an ultra violet photooxidation of the manganese-loaded/copper-depleted prion protein in the retina initiate the pathogenesis of TSE?
    Purdey M
    Med Hypotheses; 2001 Jul; 57(1):29-45. PubMed ID: 11421622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The emerging principles of mammalian prion propagation and transmissibility barriers: Insight from studies in vitro.
    Surewicz WK; Jones EM; Apetri AC
    Acc Chem Res; 2006 Sep; 39(9):654-62. PubMed ID: 16981682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scrapie infectivity is independent of amyloid staining properties of the N-terminally truncated prion protein.
    Wille H; Prusiner SB; Cohen FE
    J Struct Biol; 2000 Jun; 130(2-3):323-38. PubMed ID: 10940236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNA molecules stimulate prion protein conversion.
    Deleault NR; Lucassen RW; Supattapone S
    Nature; 2003 Oct; 425(6959):717-20. PubMed ID: 14562104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of prion protein binding proteins by combined use of far-Western immunoblotting, two dimensional gel electrophoresis and mass spectrometry.
    Strom A; Diecke S; Hunsmann G; Stuke AW
    Proteomics; 2006 Jan; 6(1):26-34. PubMed ID: 16294306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue plasminogen activator in brain tissues infected with transmissible spongiform encephalopathies.
    Xanthopoulos K; Paspaltsis I; Apostolidou V; Petrakis S; Siao CJ; Kalpatsanidis A; Grigoriadis N; Tsaftaris A; Tsirka SE; Sklaviadis T
    Neurobiol Dis; 2005 Nov; 20(2):519-27. PubMed ID: 15922607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Yin-Yang role for metals in prion disease.
    Wong BS; Brown DR; Sy MS
    Panminerva Med; 2001 Dec; 43(4):283-7. PubMed ID: 11677424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monitoring prion protein stability by NMR.
    Julien O; Graether SP; Sykes BD
    J Toxicol Environ Health A; 2009; 72(17-18):1069-74. PubMed ID: 19697241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prions at the crossroads: the need to identify the active TSE agent.
    Nandi PK
    Bioessays; 2004 May; 26(5):469-73. PubMed ID: 15112226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assembly of natural and recombinant prion protein into fibrils.
    Leffers KW; Wille H; Stöhr J; Junger E; Prusiner SB; Riesner D
    Biol Chem; 2005 Jun; 386(6):569-80. PubMed ID: 16006244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperefficient PrP Sc amplification of mouse-adapted BSE and scrapie strain by protein misfolding cyclic amplification technique.
    Fujihara A; Atarashi R; Fuse T; Ubagai K; Nakagaki T; Yamaguchi N; Ishibashi D; Katamine S; Nishida N
    FEBS J; 2009 May; 276(10):2841-8. PubMed ID: 19459939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prion protein glycosylation.
    Lawson VA; Collins SJ; Masters CL; Hill AF
    J Neurochem; 2005 May; 93(4):793-801. PubMed ID: 15857383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.